维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Taskinen M R"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterol- emia: Results of a 24 week, double-blind, randomized Phase 3 trial显示文摘	ROTH E M TASKINEN M R GINSBERG H N	2014	International Journal of Cardiology2014，176，：	1
2	Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabe- tes显示文摘	TASKINEN M R BARTER P J EHNHOLM C	2010	Diabetologia2010，53，：	1
3	Relation of plasma high density lipoprotein cholesterol to lipoprotein lipase activity in adipose tissue and skeletal muscle of man 显示文摘	NIKKILA E A TASKINEN M R KEKKI M	1978	Atherosclerosis1978，29，：	1
4	Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes显示文摘	Taskinen M R Barter P J Ehnholm C	2010	Diabetologi2010，53，9：	1
5	Diabetic dyslipidaemia: from basic research to clinical practice显示文摘	Taskinen M R	2003	Diabetologia2003，46，6：	1
6	LDL - cholesterol, HDL - cholesterol or triglyc- erides- which is the culprit? 显示文摘	TASKINEN M R	2003	Diabetes Res Clin Pract2003，61，1：	1
7	Diabetic dyslipidacmia: from basic research to clinical practice 显示文摘	TASKINEN M R	2003	Diabetologia2003，46，：	1
8	Lifestyle Modification Improves Risk Factors in Type 2 Diabetes Relatives显示文摘	Brekke H K Lenner R A Taskinen M R	2005	Diabetes Res Clin Pract JT2005，68，1：	1
9	Diabetic dyslipidaemia:from basic research to clinical practice显示文摘	Taskinen M R	2003	Diabetologia2003，46，6：	1
10	Does familial hypertriglyceridemia predispose to NIDDM? 显示文摘	SANA T TASKINEN M R	1993	Diabetes Care1993，16，11：	1
11	Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, doubleblind, randomized Phase 3 trial显示文摘	ROTH EM TASKINEN M R GINSBERG H N	2014	IntJ Cardiol2014，，：	1
12	Diabetes and quantitative lipoprotein abnormalities in diabetes mellitus显示文摘	Taskinen M R	1992	Diabetes1992，41，2：	1
13	Hyperlipidaemia in diabetes显示文摘	Taskinen M R	1990	Baillieres Clin Endocrinol Metab1990，4，4：	1
14	Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM显示文摘	Malmstr(o)m R Taskinen MR Karonen SL		0，，8：	1
15	Monotherapy with the PCSK9inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia:results of a 24week,double-blind,randomized phase 3trial显示文摘	ROTH E M TASKINEN M R GINSBERG H N	2014	Int J Cardiol2014，176，：	1
16	Zinc maybe a mediator of leptin production in humans显示文摘	CHENM D TASKINEN M R KAR0NEN S L	2000	Life Sci2000，66，22：	1
17	Insulin resistance and lipoprotein metabolism显示文摘	TASKINEN M R	1995	Curt Opin Lipidol1995，6，3：	1
18	Diabetic dyslipidaemia:from basic reseach to clinical practice显示文摘	TASKINEN M R	2003	Diabetologia2003，46，：	1
19	Insulin therapy induce antiacherogenic changes of serum lipeprocins in Non-Insulin-Dependent-Diabetics 显示文摘	Taskinen M R Kuusi T Helve E	1988	Arteriosclerosis1988，8，2：	1
20	Diabetic dyslipidaemia:From basic research to clin- ical practice显示文摘	Taskinen M R	2003	Diabetologia2003，46，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示